Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lactoferrin + ferrous fumarate
- Development stage
- Phase 2
- Lead developer
- All G
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
A combination drug consisting of lactoferrin and ferrous fumarate used primarily for the treatment of iron deficiency anemia, especially during pregnancy. Lactoferrin is an iron-binding glycoprotein that enhances iron absorption and has anti-inflammatory and antimicrobial properties. Ferrous fumarate provides the iron source. This combination has been shown to be more effective than either component alone in improving hemoglobin levels, serum iron, and other blood parameters while causing fewer gastrointestinal side effects than traditional iron supplements.
Beyond the preview
Go deeper on lactoferrin + ferrous fumarate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lactoferrin + ferrous fumarate.